The past year has been all about delivering the COVID-19 vaccine, but there's strong revenue growth from the rest of Pfizer's lineup as well. Pfizer (PFE) discovers, develops, manufactures ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Pfizer's stock ... offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker than pre-pandemic levels, and valuation analysis shows the stock ...

As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's delve into Pfizer Inc ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

But I wouldn't bet on the drugmaker's dividend yield remaining as high as it is now. A lot of negativity is baked into Pfizer's share price, with the stock trading at less than 8 times forward ...

We recently compiled a list of the 12 Best 5% Dividend Stocks To Buy According To Hedge Funds. In this article, we are going to take a look at where Pfizer ... to avoid the yield traps.

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Pfizer is currently a high-yield quality stock trading at reasonable valuations, indicating a margin of safety that surely curtails investment risks. With the stock market subject to bouts of ...